Peripartum cardiomyopathy is a form of systolic heart failure affecting young women toward
the end of pregnancy or in the months following delivery. Incidence is higher in African …

Peripartum cardiomyopathy (PPCM) is a rare, often dilated, cardiomyopathy with systolic
dysfunction that presents in late pregnancy or, more commonly, the early postpartum period …

Peripartum cardiomyopathy (PPCM) is a potentially life‐threatening condition typically
presenting as heart failure with reduced ejection fraction (HFrEF) in the last month of …

Aims An anti-angiogenic cleaved prolactin fragment is considered causal for peripartum
cardiomyopathy (PPCM). Experimental and first clinical observations suggested beneficial …

not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient's health condition …

Peripartum cardiomyopathy (PPCM) is a disease that occurs globally in all ethnic groups
and should be suspected in any peripartum women presenting with symptoms and signs of …

Peripartum cardiomyopathy (PPCM) is a potentially fatal form of idiopathic heart failure with
variable prevalence across different countries and ethnic groups. The cause of PPCM is …

Aims Peripartum cardiomyopathy (PPCM) remains a major contributor to maternal morbidity
and mortality worldwide. The disease is associated with various complications occurring …

Increased left ventricular dilation and reduced systolic function are consistently associated
with a poor prognosis and worse clinical outcomes. In this review, we discuss the …

Peripartum cardiomyopathy (PPCM) is a life-threatening cardiomyopathy characterized by
acute or slow progression of left ventricular (LV) systolic dysfunction (LV ejection fraction of< …